🔎 Trials Near Me

Home › Non-Small Cell Lung Cancer › California › Concord

Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer sa Concord, CA

14 pag-aaral para sa Non-Small Cell Lung Cancer ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Concord (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Nagre-recruitPhase 3
  • Kaiser Permanente-Walnut Creek, Walnut Creek · 5 mi ang layo
  • John Muir Medical Center-Walnut Creek, Walnut Creek · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT04267848

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Nagre-recruitPhase 3
  • Kaiser Permanente-Walnut Creek, Walnut Creek · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06498635

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

Nagre-recruitPhase 3
  • Local Institution - 0208, Pleasant Hill · 3 mi ang layo
  • BASS Cancer Center, Walnut Creek · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07361510

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Nagre-recruitPhase 3
  • John Muir Health Clinical Research Center, Concord
  • John Muir Health Cancer Center, Walnut Creek · 5 mi ang layo
  • John Muir Health Clinical Research Center, Walnut Creek · 5 mi ang layo
  • at 1 pa
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07144280

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Nagre-recruitPhase 2
  • Kaiser Permanente Walnut Creek Medical Center, Walnut Creek · 5 mi ang layo
  • John Muir Health Clinical Research Center, Walnut Creek · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06667076

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Nagre-recruitPhase 3
  • BASS Cancer Center, Walnut Creek · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06890598

Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer

Nagre-recruitObservasyonal na pag-aaral
  • John Muir Health, Walnut Creek · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07028489

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Nagre-recruitPhase 2/3
  • John Muir Clinical Research Center, Concord
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06712316

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Nagre-recruitPhase 3
  • Research Site, Walnut Creek · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT06692738

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Nagre-recruitPhase 3
  • BASS Cancer Center, Walnut Creek · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06119581

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

Nagre-recruitPhase 3
  • Research Site, Walnut Creek · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT06350097

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Nagre-recruitPhase 2
  • Kaiser Permanente-Walnut Creek, Walnut Creek · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 3, 2026 · NCT05642572

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Nagre-recruitPhase 2/3
  • Kaiser Permanente-Walnut Creek, Walnut Creek · 5 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update May 5, 2026 · NCT06616584

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Nagre-recruitObservasyonal na pag-aaral
  • Kaiser Permanente-Walnut Creek, Walnut Creek · 5 mi ang layo
  • Contra Costa Regional Medical Center, Martinez · 6 mi ang layo
  • Contra Costa Regional Medical Center, Martinez · 6 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT06418204

Pag-aaral para sa Non-Small Cell Lung Cancer sa ibang lungsod

Iba pang pag-aaral sa Concord

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.